Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for LONA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 56.89M
March 31, 2026 71.59M
December 31, 2025 205.02M
September 30, 2025 30.03M
June 30, 2025 35.54M
March 31, 2025 43.51M
December 31, 2024 58.78M
September 30, 2024 86.25M
June 30, 2024 111.25M
March 31, 2024 133.46M
December 31, 2023 160.24M
September 30, 2023 184.70M
June 30, 2023 208.05M
March 31, 2023 232.77M
Date Value
December 31, 2022 258.15M
September 30, 2022 274.18M
June 30, 2022 292.01M
March 31, 2022 313.00M
December 31, 2021 332.01M
September 30, 2021 347.33M
June 30, 2021 360.12M
March 31, 2021 369.41M
December 31, 2020 279.56M
September 30, 2020 267.94M
June 30, 2020 86.93M
March 31, 2020
December 31, 2019 2.189M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 4.649M
CNBX Pharmaceuticals, Inc. 0.0128M
GB Sciences, Inc. --
Arvinas, Inc. 675.10M
Fulcrum Therapeutics, Inc. 323.95M

Total Assets (Quarterly) Related Metrics